founder of MélanomeFrance. Particular interest in patient education and HTA.
Updated 11th June 2017 BR
special interest is patient-centered clinical trial design and alternative drug licensing models.
2013 - M-icab increasingly assumes functions outside advisory board activities and the need for a better connection of Melanoma advocates in Europe becomes apparent.
2014 -Launch of the Melanoma Patient Network Europe.
March 2014 - 1. Conference (m-icab/ESO/ MPNE2014): The trials we want.
November 2014- 1. MPNE autumn workshop: Project management for Melanoma advocates
April 2015- MPNE 2015: The risk of NOT taking risks in Melanoma.
October 2015- Melanoma Quickstart workshop for new Melanoma advocates
Novermber 2015- 2. MPNE autumn workshop: How to read a scientific paper
March 2016: MPNE 2016: Power to the Patient. With Great Power comes great responsibility.
Krusenberg 2016: Access to Innovation
Surviving Melanoma in Europe.
Access to prevention, early detection and effective treatment for all.
Melanoma Patient Network Europe
founder of Melanom Romania. Particular interest in Melanoma in Central and Eastern Europe and Clinical Trial design.
Read about our last event!
You have a Melanoma-specific problem that needs addressing on a European level? We would like to hear from you!
mission & vision
Access to prevention, early detection and effective treatment in Melanoma across Europe.
My husband's Melanoma diagnosis did not only change the life of our family forever but also my view on medicine and clinical research. We got a lot of support from others and while it will be too late for him, there will hopefully be a day when people like him will have a chance!
MD, PhD, Melanoma patient advocate